As of June 30, 2026, Galenica AG carries a market capitalization of 5.60B, placing it among publicly traded companies globally. Its enterprise value stands at 5.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 5.60B |
| Enterprise Value | 5.84B |
Galenica AG's next confirmed earnings release is scheduled for March 9, 2027.
| Earnings Date | 3/9/2027 |
As of June 30, 2026, Galenica AG has 49.82M shares outstanding.
| Shares Outstanding | 49.82M |
These figures are as of June 30, 2026.
| PB Ratio | 3.20 |
| P/TBV Ratio | -252.98 |
As of June 30, 2026, Galenica AG maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.07 |
| Quick Ratio | 0.04 |
| Debt / Equity | 16.23 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 6,558.00 |
As of the close on October 6, 2026, Galenica AG's stock has gained approximately 32.20% over the past 52 weeks.
| 52-Week Price Change | 32.20% |
As of June 30, 2026, Galenica AG holds 49.03M in cash and equivalents against 284.23M in total debt, resulting in a net debt position of -49.03M. Total book value stands at 1.75B, with working capital of 89.77M providing operational flexibility.
| Cash & Cash Equivalents | 49.03M |
| Total Debt | 284.23M |
| Net Debt | -49.03M |
| Equity (Book Value) | 1.75B |
| Book Value Per Share | 35.08 |
| Working Capital | 89.77M |
Already premium?